![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1819929
°¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå º¸°í¼ : Á¦Ç°º°, ¼ö¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)Motion Preservation Devices Market Report by Product, Surgery, End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033 |
¼¼°è °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 19¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 30¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025³âºÎÅÍ 2033³â±îÁö 5.1%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.
°¡µ¿¼º º¸Á¸ ±â±â´Â °íÁ¤¼úÀÌ ÇÊ¿ä ¾ø´Â ôÃß ÁúȯÀÇ Ä¡·á¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. Ãß°£ÆÇ Àüġȯ¼úÀº ±â´ÉÀûÀΠôÃß À¯´ÖÀÇ ¿òÁ÷ÀÓÀ» À¯ÁöÇÏ¸é¼ ¾ÈÁ¤È¸¦ Á¦°øÇϰí ÅëÁõÀ» Á¦°ÅÇÕ´Ï´Ù. À̵éÀº ÁÖ·Î Ãß°£ÆÇ Àüġȯ¼ú(TDR), Àΰø¼öÇ٠ġȯ¼ú, ÈÄ¹æ µ¿Àû ±â±â, ÆÐ½Ë ġȯ¼ú·Î ±¸¼ºµÇ¸ç, °¢°¢ ´Ù¸¥ ¸ñÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ¿¹¸¦ µé¾î, Ãß°£ÆÇ Àüġȯ¼úÀº Ãß°£ÆÇÀ» ¿ÏÀüÈ÷ Á¦°ÅÇÏ´Â µ¥ Àû¿ëµÇ¸ç, Àΰø ¼öÇ٠ġȯ¼úÀº ȯÇü Àý°³¸¦ ÅëÇØ ¼öÇÙÀ» Á¦°ÅÇØ¾ß ÇÕ´Ï´Ù. ÇöÀç´Â À¶ÇÕÇü ¼ö¼úº¸´Ù ¿îµ¿ º¸Á¸Çü ±â¼ú·Î ÀüȯµÇ°í ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó Çõ½ÅÀûÀÎ ¿îµ¿ º¸Á¸ ±â±¸ÀÇ °³¹ßÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
´Ù¾çÇÑ °¡µ¿¼º º¸Á¸ ±â±â°¡ ¿äÅëÀ¸·Î ÀÎÇÑ ÅëÁõ°ú ±â´ÉÀúÇÏ·Î °í»ýÇϴ ȯÀÚµéÀÇ ´ëüġ·á ¹× º¸Á¶¿ä¹ýÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â Èí¿¬, ºñ¸¸, ÁÂ½Ä »ýȰ½À°üÀ¸·Î ÀÎÇÑ Ã´Ãß ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÇÔ²² ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ¿äÃß°ü ÇùÂøÁõ, ÅðÇ༺ Ãß°£ÆÇÁõ, °ñ°üÀý¿°À¸·Î ÀÎÇÑ ¼Ò¸éü ÅëÁõ µîÀÇ Áõ»óÀ» Ä¡·áÇϱâ À§ÇÑ ¼ö¼ú °Ç¼ö°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Àü ¼¼°è °¡µ¿¼º º¸Á¸ ±â±â¿¡ ´ëÇÑ ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ¿©·¯ ÁÖ¿ä ±â¾÷µéÀÌ Ã·´Ü ±â¼úÀ» žÀçÇÑ Â÷¼¼´ë ±â±â¸¦ Ãâ½ÃÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®´ÙÁÖ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ÇコÄÉ¾î ±â¾÷ Aesculap, Inc.´Â Áö´ÉÇü ¸ð¼Ç ±â¼úÀ» žÀçÇÑ activL Àΰø Ãß°£ÆÇÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Àΰø Ãß°£ÆÇÀº ÅðÇ༺ µð½ºÅ© Áúȯ(DDD) ȯÀÚ¸¦ À§ÇÑ 3¼¼´ë ¿îµ¿ À¯Áö ±â±â·Î, °Ç°ÇÑ Àΰ£ ôÃßÀÇ ÀÚ¿¬ »ýü¿ªÇаú À¯»çÇÏ¿© ÀÎÁ¢ÇÑ ¼öÁØÀÇ ÇØºÎÇÐÀû ±¸Á¶¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Å©°Ô ÁÙÀÔ´Ï´Ù.
The global motion preservation devices market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033.
Motion preservation devices are utilized in the treatment of several spine conditions without fusion. They provide stabilization and eliminate pain while preserving the motion of the functional spinal unit. They mainly comprise total disc replacement (TDR), prosthetic nucleus replacement, posterior dynamic devices, and facet replacement, which are used for different purposes. For example, TDRs find application in the complete removal of the disc, while prosthetic nucleus replacements necessitate evacuation of the nucleus pulposus through an annulotomy. Nowadays, a shift towards motion-sparing technology over fusion-type procedures is resulting in the increasing development of innovative motion-preserving devices.
A wide variety of motion preservation devices are used as treatment alternatives or adjuncts for patients suffering from pain and loss of function caused by back issues. This, in confluence with the rising prevalence of spine problems on account of smoking, obesity, and sedentary lifestyles, represents one of the major factors driving the market. In addition, the growing geriatric population is resulting in a significant increase in the number of surgeries utilized for treating symptoms of lumbar spinal stenosis, degenerative disc disease, and facet pain from osteoarthritis. This is positively influencing the demand for motion preservation devices across the globe. Apart from this, several leading companies are introducing next-generation devices with advanced technology, which is creating a positive outlook for the market. For instance, Aesculap, Inc., a US-based healthcare company, launched the activL artificial disc with intelligent motion technology. It is a third-generation motion preservation device for degenerative disc disease (DDD) patients, which resembles the natural biomechanics of the healthy human spine and significantly reduces the impact on adjacent level anatomy.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aurora Spine Inc, B. Braun Melsungen AG, Globus Medical, HPI Implants, Johnson & Johnson Private Limited, Medtronic, NuVasive Inc., Orthofix Medical Inc, Surgalign, ulrich GmbH & Company KG, and Zimmer Biomet.